Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression "ONTIME Pilot"


Phase 4 Results N/A

Summary of Purpose

The purpose of this study is to investigate if early administration (i.e. within 12 weeks after stroke) of Dysport® 500 U injections may delay the appearance of the progression of upper limb symptomatic spasticity.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 April 2016.

1 Dec 2014 17 Dec 2014 1 Mar 2016 1 Mar 2016 1 Apr 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment